Aqueous core nanocapsules: a new solution for encapsulating doxorubicin hydrochloride

References

• Couvreur P, Barratt G, Fattal E, Legrand P, Vauthier C. (2002). Nanocapsule technology: a review. Crit Rev Ther Drug Carrier Syst, 19:99–134.
   PubMed Web of Science ®Google Scholar
• Lambert G, Fattal E, Pinto-Alphandary H, Gulik A, Couvreur P. (2000). Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides. Pharm Res, 17:707–714.
   PubMed Web of Science ®Google Scholar
• Hillaireau H, Le Doan T, Chacun H, Janin J, Couvreur P. (2007). Encapsulation of mono- and oligo-nucleotides into aqueous-core nanocapsules in presence of various water-soluble polymers. Int J Pharm, 331:148–152.
   PubMed Web of Science ®Google Scholar
• Anton N, Benoit JP, Saulnier P. (2008). Design and production of nanoparticles formulated from nano-emulsion templates-a review. J Control Release, 128:185–199.
   PubMed Web of Science ®Google Scholar
• Anton N, Saulnier P, Gaillard C, Porcher E, Vrignaud S, Benoit JP. (2009). Aqueous-core lipid nanocapsules for encapsulating fragile hydrophilic and/or lipophilic molecules. Langmuir, 25:11413–11419.
   PubMed Web of Science ®Google Scholar
• Vrignaud S, Benoit JP, Saulnier P. (2011). Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles. Biomaterials, 32:8593–8604.
   PubMed Web of Science ®Google Scholar
• Hillaireau H, Le Doan T, Besnard M, Chacun H, Janin J, Couvreur P. (2006). Encapsulation of antiviral nucleotide analogues azidothymidine-triphosphate and cidofovir in poly(iso-butylcyanoacrylate) nanocapsules. Int J Pharm, 324:37–42.
   PubMed Web of Science ®Google Scholar
• Paiphansiri U, Dausend J, Musyanovych A, Mailänder V, Landfester K. (2009). Fluorescent polyurethane nanocapsules prepared via inverse miniemulsion: surface functionalization for use as biocarriers. Macromol Biosci, 9:575–584.
   PubMed Web of Science ®Google Scholar
• Baier G, Musyanovych A, Dass M, Theisinger S, Landfester K. (2010). Cross-linked starch capsules containing dsDNA prepared in inverse miniemulsion as “nanoreactors” for polymerase chain reaction. Biomacromolecules, 11:960–968.
   PubMed Web of Science ®Google Scholar
• Rosenbauer EM, Landfester K, Musyanovych A. (2009). Surface-active monomer as a stabilizer for polyurea nanocapsules synthesized via interfacial polyaddition in inverse miniemulsion. Langmuir, 25:12084–12091.
   PubMed Web of Science ®Google Scholar
• Mdicaments antitumoraux et perspectives dans le traitement des cancers; vol. 6; chap. AFECT: Anthracyclines utilises en thrapeutique 2003, 364–411.
   Google Scholar
• Allen A. (1992). The cardiotoxicity of chemotherapeutic drugs. Semin Oncol, 19:529–542.
   PubMed Web of Science ®Google Scholar
• Fundarò A, Cavalli R, Bargoni A, Vighetto D, Zara GP, Gasco MR. (2000). Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats. Pharmacol Res, 42:337–343.
   PubMed Web of Science ®Google Scholar
• Janes KA, Fresneau MP, Marazuela A, Fabra A, Alonso MJ. (2001). Chitosan nanoparticles as delivery systems for doxorubicin. J Control Release, 73:255–267.
   PubMed Web of Science ®Google Scholar
• Wong HL, Rauth AM, Bendayan R, Manias JL, Ramaswamy M, Liu Z et al. (2006). A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells. Pharm Res, 23:1574–1585.
   PubMed Web of Science ®Google Scholar
• Park JH, Cho YW, Son YJ, Kim K, Chung H, Jeong SY et al. (2006). Preparation and characterization of self-assembled nanoparticles based on glycol chitosan-bearing adriamycin. Colloid Polym Sci, 284:763–770.
   Web of Science ®Google Scholar
• Rahman AM, Yusuf SW, Ewer MS. (2007). Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation. Int J Nanomedicine, 2:567–583.
   PubMed Web of Science ®Google Scholar
• Cho HJ, Yoon IS, Yoon HY, Koo H, Jin YJ, Ko SH et al. (2012). Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin. Biomaterials, 33:1190–1200.
   PubMed Web of Science ®Google Scholar
• Liu Y, Mi Y, Zhao J, Feng SS. (2011). Multifunctional silica nanoparticles for targeted delivery of hydrophobic imaging and therapeutic agents. Int J Pharm, 421:370–378.
   PubMed Web of Science ®Google Scholar
• Vrignaud S, Anton N, Gayet P, Benoit JP, Saulnier P. (2011). Reverse micelle-loaded lipid nanocarriers: a novel drug delivery system for the sustained release of doxorubicin hydrochloride. Eur J Pharm Biopharm, 79:197–204.
   PubMed Web of Science ®Google Scholar
• Jagielski N, Sharma S, Hombach V, Mailander V, Rasche V, Landfester K. (2007). Nanocapsules synthesized by miniemulsion technique for application as new contrast agent materials. Macromol Chem Phys, 208:2229–2241.
   Web of Science ®Google Scholar
• Crespy D, Stark M, Hoffmann-Richter C, Ziener U, Landfester K. (2007). Polymeric nanoreactors for hydrophilic reagents synthesized by interfacial polycondensation on miniemulsion droplets. Macromolecules, 40:3122–3135.
   Web of Science ®Google Scholar
• El-Gibaly I, Anwar M. (2004). Hemolysate-filled polyethyleneimine and polyurea microcapsules as potential red blood cell substitutes: effect of aqueous monomer type on properties of the prepared microcapsules. Int J Pharm, 278:25–40.
   PubMedGoogle Scholar
• Soma CE, Dubernet C, Bentolila D, Benita S, Couvreur P. (2000). Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles. Biomaterials, 21:1–7.
   PubMed Web of Science ®Google Scholar
• Rahimi M, Wadajkar A, Subramanian K, Yousef M, Cui W, Hsieh JT et al. (2010). In vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled drug delivery. Nanomedicine, 6:672–680.
   PubMed Web of Science ®Google Scholar
• Siepmann J, Peppas NA. (2001). Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev, 48:139–157.
   PubMed Web of Science ®Google Scholar
• Missirlis D, Kawamura R, Tirelli N, Hubbell JA. (2006). Doxorubicin encapsulation and diffusional release from stable, polymeric, hydrogel nanoparticles. Eur J Pharm Sci, 29:120–129.
   PubMed Web of Science ®Google Scholar
• Vonarbourg A, Passirani C, Saulnier P, Simard P, Leroux JC, Benoit JP. (2006). Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. J Biomed Mater Res A, 78:620–628.
   PubMed Web of Science ®Google Scholar
• Béduneau A, Saulnier P, Anton N, Hindré F, Passirani C, Rajerison H et al. (2006). Pegylated nanocapsules produced by an organic solvent-free method: Evaluation of their stealth properties. Pharm Res, 23:2190–2199.
   PubMed Web of Science ®Google Scholar